LBPH — Longboard Pharmaceuticals Balance Sheet
0.000.00%
- $2.34bn
- $2.05bn
- 37
- 22
- 91
- 48
Annual balance sheet for Longboard Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 55.3 | 107 | 67.6 | 48.5 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 55.4 | 108 | 69.8 | 50.2 |
| Net Property, Plant And Equipment | — | 0.535 | 0.745 | 0.476 |
| Other Long Term Assets | ||||
| Total Assets | 56.2 | 109 | 70.6 | 50.7 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Current Liabilities | 3.13 | 5.44 | 8.76 | 9.77 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 3.13 | 5.63 | 9.15 | 9.77 |
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 53.1 | 103 | 61.5 | 40.9 |
| Total Liabilities & Shareholders' Equity | 56.2 | 109 | 70.6 | 50.7 |
| Total Common Shares Outstanding |